Final results from NSABP protocol R-04: Neoadjuvant chemoradiation (RT) comparing continuous infusion (CIV) 5-FU with capecitabine (Cape) with or without oxaliplatin (Ox) in patients with stage II and III rectal cancer.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Final results from NSABP protocol R-04: Neoadjuvant chemoradiation (RT) comparing continuous infusion (CIV) 5-FU with capecitabine (Cape) with or without oxaliplatin (Ox) in patients with stage II and III rectal cancer.

Published:2014-05-20 Issue:15_suppl Volume:32 Page:3603-3603
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Allegra Carmen Joseph¹,Yothers Greg²,O'Connell Michael J.³,Roh Mark S.⁴,Lopa Samia H.²,Petrelli Nicholas J.⁵,Beart Robert W.⁶,Sharif Saima³,Wolmark Norman⁷

Affiliation:

1. University of Florida, Gainesville, FL

2. NSABP Biostatistical Center, and University of Pittsburgh Graduate School of Public Health, Department of Biostatistics, Pittsburgh, PA

3. NSABP, Pittsburgh, PA

4. NSABP, and UF Health Cancer Center-Orlando Health, Orlando, FL

5. NSABP, and Helen F. Graham Cancer Center & Research Institute, Newark, DE

6. NSABP, and Glendale Memorial Hospital, Glendale, CA

7. NSABP, and Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.15_suppl.3603

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer;The Cancer Journal;2024-07

2. Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer;Medicina;2024-04-19

3. Strategies to Optimize Treatment for Locally Advanced Rectal Cancer;Cancers;2022-12-29

4. Retrospective study of preoperative chemoradiotherapy with capecitabine versus capecitabine plus oxaliplatin for locally advanced rectal cancer;Scientific Reports;2020-07-27

5. Defining Early Multidisciplinary Goals: NEXTO Trial in High-Risk Colorectal Cancer with Liver Metastases;Annals of Surgical Oncology;2020-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3